Amniotic membrane transplantation in severe bacterial keratitis

Cornea

Volumn 26, Issue 1, 2007, Pages 27-33

  Gicquel, Jean Jacques ^a   Bejjani, Riad A ^a,b   Ellies, Pierre ^a   Mercié, Martial ^a   Dighiero, Paul ^a  

^a University of Poitiers   (France)

^b SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

Amniotic membrane; Bacterial keratitis; Corneal healing; Fortified antibiotic eyedrops

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ATROPINE; CEFTAZIDIME; DEXAMETHASONE; DEXTROPROPOXYPHENE; PARACETAMOL; STEROID; VANCOMYCIN;

ADULT; AGED; AMNION; AMNIOTIC MEMBRANE TRANSPLANTATION; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CORNEA EPITHELIUM; DISEASE SEVERITY; EYE INFECTION; EYE SURGERY; FEMALE; FOLLOW UP; HEALING; HOSPITAL ADMISSION; HUMAN; KERATITIS; KLEBSIELLA PNEUMONIAE; MALE; MORAXELLA CATARRHALIS; NEOVASCULARIZATION (PATHOLOGY); PAIN; PAIN ASSESSMENT; PERFORATING EYE INJURY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AMIKACIN; AMNION; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; COMBINED MODALITY THERAPY; CORNEAL ULCER; DRUG THERAPY, COMBINATION; EPITHELIUM, CORNEAL; EYE INFECTIONS, BACTERIAL; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PROSPECTIVE STUDIES; VANCOMYCIN; WOUND HEALING;

EID: 33846029846     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31802b28df     Document Type: Article

References (39)

1. Gangopadhyay N, Daniell M, Weih L, et al. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Br J Ophthalmol. 2000;84:378-384.
2. Anderson DF, Ellies P, Pires RT, et al. Amniotic membrane transplantation for partial limbal stem cell deficiency. Br J Ophthalmol. 2001;85:567-575.
3. Solomon A, Meller D, Prabhasawat P, et al. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology. 2002;109:694-703.
4. Ellies P, Anderson D, Dighiero P, et al. Mise au point sur la membrane amniotique humaine dans la prise en charge des pathologies de la surface oculaire. J Fr Ophtalmol. 2001;24:546-556.
5. Dua HS, Gomes JA, King AJ, et al. The amniotic membrane in ophthalmology. Surv Ophthalmol. 2004;49:51-77.
6. Dua HS, King AJ, Joseph A. A new classification of ocular surface burns. Br J Ophthalmol. 2001;85:1379-1383.
7. Joseph A, Dua HS, King AJ. Failure of amniotic membrane transplantation in the treatment of acute ocular burns. Br J Ophthalmol. 2001;85:1065-1069.
8. Kobayashi A, Shirao Y, Yoshita T, et al. Temporary amniotic membrane patching for acute chemical burns. Eye. 2003;17:149-158.
9. Kim JS, Kim JC, Hahn TW, et al. Amniotic membrane transplantation in infectious corneal ulcer. Cornea. 2001;20:720-726.
10. Ma DH, Wang SF, Su WY, et al. Amniotic membrane graft for the management of scleral melting and corneal perforation in recalcitrant infectious scleral and corneoscleral ulcers. Cornea. 2002;21:275-283.
11. Heiligenhaus A, Bauer D, Meller D, et al. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest Ophthalmol Vis Sci. 2001;42:1969-1974.
12. Singh G, Foster CS. Gross factors in treatment of nonhealing corneal ulcers and recurrent erosions. Cornea. 1989;8:45-53.
13. Lambiase A, Bonini S, Aloe L, et al. Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch Ophthalmol. 2000;118:1446-1449.
14. Bourcier T, Forgez P, Borderie V, et al. Regulation of human corneal epithelial cell proliferation and apoptosis by dexamethasone. Invest Ophthalmol Vis Sci. 2000;41:4133-4141.
15. Baum J, Dabezies OH Jr. Pathogenesis and treatment of "sterile" midperipheral corneal infiltrates associated with soft contact lens use. Cornea. 2000;19:777-781.
16. Wilhelmus KR. Indecision about corticosteroids for bacterial keratitis an evidence-based update. Ophthalmology. 2002;109:835-842.
17. Wang JC, Su D, Lim L. Contact lens microbial keratitis and prior topical steroid use: a disaster in the making? Ann Acad Med Singapore. 2004;33:484-488.
18. Gopinathan U, Stapleton F, Sharma S, et al. Microbial contamination of hydrogel contact lenses. J Appl Microbiol. 1997;82:653-658.
19. Fosnocht DEDJ, Swanson ER. Measuring pain intensity in the emergency department: correlation of a numeric rating scale with a visual analog scale. Acad Emerg Med. 2003;10:484.
20. Bourcier T, Thomas F, Borderie V, et al. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol. 2003;87:834-838.
21. Brown SI, Bloomfield SE, Tam W. The cornea-destroying enzyme of Pseudomonas aeruginosa. Invest Ophthalmol. 1974;13:174-180.
22. Giamarellou H. Therapeutic guidelines for Pseudomonas aeruginosa infections. Int J Antimicrob Agents. 2000;16:103-106.
23. Twining SS, Kirschner SE, Mahnke LA, et al. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest Ophthalmol Vis Sci. 1993;34:2699-2712.
24. Holland SP, Pulido JS, Shires TK, et al. Pseudomonas aeruginosa ocular infections. In: Fick RB Jr, ed. Pseudomonas aeruginosa the Opportunist. Pathogenesis and Disease. Boca Raton, FL: CRC Press; 1993:159-176.
25. Kernacki KA, Goebel DJ, Poosch MS, et al. Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection in mice. Infect Immun. 1998;66:376-379.
26. Wilhelmus K. Bacterial keratitis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St. Louis, MO: Mosby; 1996:970-1032.
27. Espana EM, Grueterich M, Sandoval H, et al. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg. 2003;29:279-284.
28. Kim JS, Kim JC, Na BK, et al. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res. 2000;70:329-337.
29. Koizumi N, Fullwood NJ, Bairaktaris G, et al. Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest Ophthalmol Vis Sci. 2000;41:2506-2513.
30. Tseng SC. Amniotic membrane transplantation for persistent corneal epithelial defect. Br J Ophthalmol. 2001;85:1400-1401.
31. Wang MX, Gray TB, Park WC, et al. Reduction in corneal haze and apoptosis by amniotic membrane matrix in excimer laser photoablation in rabbits. J Cataract Refract Surg. 2001;27:310-319.
32. Lambiase A, Sacchetti M, Sgrulletta R, et al. Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer: a case report. Eur J Ophthalmol. 2005;15:274-276.
33. Kjaergaard N, Hein M, Hyttel L, et al. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol. 2001;94:224-229.
34. Kjaergaard N, Helmig RB, Schonheyder HC, et al. Chorioamniotic membranes constitute a competent barrier to group B Streptococcus in vitro. Eur J Obstet Gynecol Reprod Biol. 1999;83:165-169.
35. Rodriguez-Ares MT, Tourino R, Lopez-Valladares MJ, et al. Multilayer amniotic membrane transplantation in the treatment of corneal perforations. Cornea. 2004;23:577-583.
36. Silbert JA. A review of therapeutic agents and contact lens wear. J Am Optom Assoc. 1996;67:165-172.
37. Foulks GN. Prolonging contact lens wear and making contact lens wear safer. Am J Ophthalmol. 2006;141:369-373.
38. Willoughby CE, Batterbury M, Kaye SB. Collagen corneal shields. Surv Ophthalmol. 2002;47:174-182.
39. Tseng SC. 2006. "Research Experiences" (2002 Developing and tissue engineering of sutureless AmnioLens). Available at http://www. ocularsurface.com/personaldata_research.html#2d1. Accessed November 9, 2006.